Location of Repository

A study of the efficacy and cost-effectiveness of MRSA screening and\ud monitoring on surgical wards using a new, rapid molecular test\ud (EMMS)

By K. (Katherine) Hardy, Ala Szczepura, Ruth Davies, Andrew Bradbury, Nigel Stallard, Savita Gossain, Paul Walley and P. M. (Peter M.) Hawkey

Abstract

Background: MRSA is a significant contributor to prolonged hospital stay, poor clinical outcome\ud and increased healthcare costs amongst surgical patients. A PCR test has been developed for rapid\ud detection of MRSA in nasal swabs. The aims of this study are (1) to estimate the effectiveness of\ud screening using this rapid PCR tests vs culture in reducing MRSA cross-infection rates; (2) to\ud compare the cost of each testing strategy, including subsequent health care costs; and (3) to model\ud different policies for the early identification and control of MRSA infection in surgical patients.\ud Methods/Design: The study is a prospective two-period cross-over study set in 7 surgical wards\ud covering different surgical specialities. A total of 10,000 patients > 18 years will be tested over 16\ud months. The only difference between the two study periods is the method used for the detection\ud of MRSA in each ward (rapid v conventional culture), with all other infection control practices\ud remaining consistent between the arms. The study has been designed to complement routine\ud practice in the NHS. Outcomes are MRSA cross-infection rates (primary outcome) and need for\ud antibiotic therapy and MRSA-related morbidity. Parallel economic and modelling studies are being\ud conducted to aid in the interpretation of the results and to evaluate the cost-effectiveness of the\ud rapid PCR screening strategy.\ud Discussion: This paper highlights the design, methods and operational aspects of a study evaluating\ud rapid MRSA screening in the surgical ward setting

Topics: RA0421
Publisher: Biomed central
Year: 2007
OAI identifier: oai:wrap.warwick.ac.uk:131

Suggested articles

Preview

Citations

  1. (2006). A: Community-associated meticillin-resistant Staphylococcus aureus: nosocomial transmission in a neonatal unit. J Hosp Infect doi
  2. (1997). A: The population impact of MRSA in a country: the national survey of MRSA in Wales, doi
  3. (2002). AE: Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay. doi
  4. (1998). Brun-Buisson C: Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis doi
  5. (2007). BSAC Method for antimicrobial susceptibility testing. doi
  6. (1994). C: Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. doi
  7. (2006). Controlling methicillinresistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. doi
  8. (2002). Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. doi
  9. (2001). Deaths involving MRSA: England and Wales, doi
  10. (2006). DS: Evaluation of three chromogenic media (MRSA-ID, MRSA-Select and CHROMagar MRSA) and ORSAB for surveillance cultures of methicillinresistant Staphylococcus aureus. Clin Microbiol Infect doi
  11. (2004). Ebrahim S: Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ doi
  12. (2003). Ebrahim S: Systematic review of isolation policies in the hospital management of methicillinresistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess doi
  13. (2001). FJ: Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. doi
  14. (1990). GW: Methods for the economic evaluation of health care programmes.
  15. (2005). MG: Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program. Clin Infect Dis doi
  16. (2004). MG: New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. doi
  17. (2004). PM: Distribution and characterization of staphylococcal interspersed repeat units (SIRUs) and potential use for strain differentiation. doi
  18. (2002). Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. doi
  19. (1997). Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect doi
  20. (2007). S: Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. doi
  21. (2003). Towner KJ: Detection of methicillin-resistant Staphylococcus aureus (MRSA) in blood with the EVIGENE MRSA detection kit. doi
  22. (1999). Towner KJ: Evaluation of the mecA femB duplex polymerase chain reaction for detection of methicillin-resistant Staphylococcus aureus. doi
  23. (1996). Unit costs of health and social care.
  24. (2005). X: Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units. Crit Care doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.